X

Create an account to continue reading.

Registered readers have access to our blogs and a limited number of magazine articles
For unlimited access to The Spectator, subscribe below

Registered readers have access to our blogs and a limited number of magazine articles

Sign in to continue

Already have an account?

What's my subscriber number?

Subscribe now from £1 a week

Online

Unlimited access to The Spectator including the full archive from 1828

Print

Weekly delivery of the magazine

App

Phone & tablet edition of the magazine

Spectator Club

Subscriber-only offers, events and discounts
 
View subscription offers

Already a subscriber?

or

Subscribe now for unlimited access

ALL FROM JUST £1 A WEEK

View subscription offers

Thank you for creating your account – To update your details click here to manage your account

Thank you for creating your account – To update your details click here to manage your account

Thank you for creating an account – Your subscriber number was not recognised though. To link your subscription visit the My Account page

Thank you for creating your account – To update your details click here to manage your account

X

Login

Don't have an account? Sign up
X

Subscription expired

Your subscription has expired. Please go to My Account to renew it or view subscription offers.

X

Forgot Password

Please check your email

If the email address you entered is associated with a web account on our system, you will receive an email from us with instructions for resetting your password.

If you don't receive this email, please check your junk mail folder.

X

It's time to subscribe.

You've read all your free Spectator magazine articles for this month.

Subscribe now for unlimited access – from just £1 a week

You've read all your free Spectator magazine articles for this month.

Subscribe now for unlimited access

Online

Unlimited access to The Spectator including the full archive from 1828

Print

Weekly delivery of the magazine

App

Phone & tablet edition of the magazine

Spectator Club

Subscriber-only offers, events and discounts
X

Sign up

What's my subscriber number? Already have an account?

Thank you for creating your account – To update your details click here to manage your account

Thank you for creating your account – To update your details click here to manage your account

Thank you for creating an account – Your subscriber number was not recognised though. To link your subscription visit the My Account page

Thank you for creating your account – To update your details click here to manage your account

X

Your subscriber number is the 8 digit number printed above your name on the address sheet sent with your magazine each week.

Entering your subscriber number will enable full access to all magazine articles on the site.

If you cannot find your subscriber number then please contact us on customerhelp@subscriptions.co.uk or call 0330 333 0050.

You can create an account in the meantime and link your subscription at a later time. Simply visit the My Account page, enter your subscriber number in the relevant field and click 'submit changes'.

Please note: Previously subscribers used a 'WebID' to log into the website. Your subscriber number is not the same as the WebID. Please ensure you use the subscriber number when you link your subscription.

The Week

UK Drugs Policy Commission responds to Melanie Phillips

27 May 2008

7:10 PM

27 May 2008

7:10 PM

Melanie Phillips makes three allegations about the UK Drug Policy Commission in her 22 May Spectator Blog, “Britain’s Drug Wars”.

First is that we are a “bunch of self appointed busybodies of no status or authority whatsoever”. As a charity we may be self-appointed but a quick look at our web-site would have shown that our Commissioners are people of significant stature and reputation in their respective fields.

[Alt-Text]


Second is that we are “intent on bringing about the legalisation of drugs”. This is an absolute travesty and a wilful misrepresentation of our work which is aimed at supporting a more informed public and political debate about addressing issues of drug policy and practice in the UK through the use of sound evidence. An examination of our recently published evidence review “Reducing Drug Use & Reducing Reoffending” would have shown any rookie journalist that the Commission could in no way be accused of being closet “legalisers”. Its first conclusion was that the principle of using criminal justice system-based interventions to encourage engagement with treatment is supported by the international and much domestic evidence.

Finally she asks why the UKDPC research is “not being opened up to public scrutiny like other research?”. There is no secret or conspiracy in the work we are doing-it is all publicly accessible through our web site (including our submission to the ACMD about cannabis reclassification). We are currently working on four major pieces of work: shortly we will be publishing a review of the international evidence for the effectiveness of efforts to tackle drug markets and distribution networks in the UK. This has led on to new work to consider how the benefits of enforcement activity can be optimised to reduce drug related harms. Other work is looking at building a consensus amongst those engaged with drug treatment about the central importance of recovery. We also have two other areas of activity, one looking at getting problem drug users (back) into employment with a special focus on employers needs, and another examining the support provided by families of addicts during recovery and their own support needs.

The revolution we seek is not the legalisation of drugs. Rather it is the objective that politicians, the media and the public will increasingly use science and the evidence base to have a more informed dialogue about drug policy.  Our contribution to the Advisory Council on the Misuse of Drugs meeting was not a formal submission of evidence as suggested but an update on our work programme so the Council could take it into consideration  where relevant in the wide range of valuable work they undertake.

Dame Ruth Runciman
Chair UK Drug Policy Commission

Subscribe to The Spectator today for a quality of argument not found in any other publication. Get more Spectator for less – just £12 for 12 issues.


Show comments
Close